Cart
sales@molnova.com
TDI-011536
CAS No. 2687970-96-1
TDI-011536( —— )
Catalog No. M35339 CAS No. 2687970-96-1
TDI-011536, a potent Lats kinase inhibitor, disrupts Hippo-Yap signaling and promotes the proliferation of lesioned heart muscle cells. This compound is valuable for research in organ conservation and regeneration.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 48 | In Stock |
|
| 10MG | 76 | In Stock |
|
| 25MG | 163 | In Stock |
|
| 50MG | 259 | In Stock |
|
| 100MG | 423 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTDI-011536
-
NoteResearch use only, not for human use.
-
Brief DescriptionTDI-011536, a potent Lats kinase inhibitor, disrupts Hippo-Yap signaling and promotes the proliferation of lesioned heart muscle cells. This compound is valuable for research in organ conservation and regeneration.
-
DescriptionTDI-011536 is a potent Lats kinase inhibitor, interrupts Hippo-Yap signaling and initiates the proliferation of lesioned heartmuscle cells. TDI-011536 can be used in studies of organ conservation and regeneration.
-
In VitroCell Proliferation Assay Cell Line:human retinal organoids Concentration:3 μM Incubation Time:24 h, 5 days Result:Supressed Yap phosphorylation and promoted Müller glia proliferation.
-
In VivoAnimal Model:Living mice (immunoblot analysis of the heart, liver, and skin immediately after injection).Dosage:200 mg/kg Administration:Intraperitoneal injections; once.Result:Reduced the amount of pYap for at least 4 h after injection in all three organs and the levels returned to control values within a day.Animal Model:Male 8-week-old mice (cryolesion model).Dosage:100 mg/kg Administration:Intraperitoneal injections; once daily for 2 or 3 days.Result:Promoted cardiomyocytes proliferation.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2687970-96-1
-
Formula Weight364.42
-
Molecular FormulaC19H16N4O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (343.01 mM; Ultrasonic )
-
SMILESOCc1cs\c(=N/C(=O)c2c[nH]c3ncccc23)n1Cc1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kastan NR, et al. Development of an improved inhibitor of Lats kinases to promote regeneration of mammalian organs. Proc Natl Acad Sci U S A. 2022 Jul 12;119(28):e2206113119. ?
molnova catalog
related products
-
(Phe1,Ser2)-TRAP-6
(Phe1,Ser2)-TRAP-6
-
Labetuzumab
Labetuzumab is a humanized anti-carcinoembryonic antigen (CEA) monoclonal antibody with anticancer activity that inhibits tumor growth and is used in the study of thyroid and colorectal cancer (CRC).
-
IKKγ NBD Inhibitory ...
A cell-permeable synthetic peptide NEMO-binding domain peptide (NBD peptide) corresponding to the NEMO amino-terminal alpha-helical region is shown to block TNF-alpha-induced NF-kB activation. The interaction of IKγNEMO with the IKK complex is vital for the activation of the IKK complex and the subsequent activation of NF-kB.
